Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis

Clinical trial NCT05260073 · COMPLETED

Trial details

NCT number: NCT05260073
Sponsor: Almirall, S.A.
Status: COMPLETED
Study type: OBSERVATIONAL

Keratosis, Actinic

Start date: 2022-03-09
Primary completion: 2022-10-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.